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Mycotic aortic aneurysms are rare complications of systemic tuberculosis that affect very few patients. We report a case of
a false aneurysm of the visceral segment of the aorta that was associated with tuberculous vertebral osteomyelitis. Both
conditions were successfully treated with antituberculous chemotherapy and a combined surgical procedure, ie, aneurysm
resection and homograft implantation, followed by orthopedic stabilization of the spine. (J Vasc Surg 2005;42:
1010-1013.)The incidence of infections with Mycobacterium tuber-
culosis has been increasing worldwide during the last de-
cade. In Western Europe and the United States, current
threats from tuberculosis (TB) have basically resulted from
three factors: (1) migration from countries with a high TB
incidence, (2) the appearance of M tuberculosis strains re-
sistant to the commonly used chemotherapeutic agents,
and (3) the continuing increase of the human immunode-
ficiency epidemic.1,2 An affection of the spine, also termed
Pott disease, occurs in less than 1% of all TB cases.3 Be-
tween 1945 and 2004, only 56 cases of tuberculous aortic
aneurysms were published.4,5 Accordingly, a combination
of both entities is extremely rare.
CASE REPORT
A 61-year-old white man presented at a primary care hospital
with a 6-month history of recurrent fever. His disease was diag-
nosed as miliary TB. A computed tomography (CT) scan revealed
spondylodiscitis and a contiguous false aneurysm of the paravis-
ceral aorta, with a maximum diameter of 6.7 cm (Figs 1 and 2).
Antituberculous chemotherapy was initiated with ethambu-
tol, rifampin, isoniazid, and pyrazinamide. The occurrence of
paraparesis on the fifth day after admission indicated the necessity
to decompress and stabilize the spine. However, the risk of intra-
operative rupture of the contiguous false aneurysm was high. A
synchronous repair of both pathologic entities was considered to
be adequate treatment. Initially, a temporal extracorporeal left
axillofemoral bypass was installed to allow retrograde perfusion of
the lower abdominal aorta during the expected prolonged clamp-
ing time. A posterolateral thoracoabdominal exposure was per-
formed via an incision along the left ninth intercostal space. After
incision of the diaphragm, the descending and suprarenal aorta was
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1010isolated, clamped, and incised laterally below the celiac trunk. The
false aneurysm arose from a 3 4-cm defect in the posterior wall of
the aorta. The affected vessel segment was resected, and this left
the superior mesenteric artery together with the renal arteries and
the celiac trunk on alternate ends of the remaining aortic segments.
Reconstruction was performed by using an aortic homograft that
had been taken from a donor 15 days earlier and stored at 4°C in a
solution for organ preservation (Via Span; Bristol-Myers Squibb
GmbH, Regensburg, Germany) containing penicillin G 200,000
U/L.
The orthopedic procedure included a subtotal corporectomy
of the 11th and 12th thoracic vertebrae and the 1st lumbar
vertebra, followed by a partial resection of the posterior walls and
meticulous removal of the inflammatory tissue in the spinal canal.
Anterior stabilization was performed by use of a titanium mesh
cage filled with bone cement, followed by anterior instrumentation
of T11 to L2 using a double-screw, double-rod system.
The patient was discharged 12 weeks after surgery. A mild
weakness of the extensormuscles of the lower extremities remained
as a residual neurologic symptom, with normal sensory functions.
Antituberculous chemotherapy consisted of pyrazinamide (2
months), isoniazid, rifampin, and ethambutol. Because of bilateral
optic neuritis and progressive peripheral neuropathy, antitubercu-
lous chemotherapy was discontinued after 5 months. However,
magnetic resonance tomography of the spine performed 4 weeks
later revealed discitis between the spinal segments T2 and T3 with
infiltration of the peridural space. No pathogen could be cultivated
from material obtained by CT-guided biopsies. On clinical
grounds, antibiotic treatment was restarted with rifampin and
pyrazinamide and was terminated after a full course of 12 months.
A CT scan performed 15 months after surgery confirmed a regular
homograft function with normal perfusion of the enteric and renal
arteries. The orthopedic reconstruction had mended and was
stable. The focus at the upper thoracic spine was fibrosed and
revealed no sign of spinal compression or active inflammation. The
visual functions had recovered, but a peripheral neurologic deficit
remained.
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Volume 42, Number 5 Falkensammer et al 1011Fig 1. Computed tomography–based three-dimensional reconstruction of the localized saccular aneurysm of the
thoracoabdominal aorta and the contiguous collapsed vertebral segments T12 to L1 (the image displays the contrast
media–perfused lumen only). The arrow indicates the level of the transverse image (Fig 2).
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Spinal TB most frequently involves the vertebral
bodies of the thoracolumbar spine and the intervening
disk spaces.1 Symptoms are usually slowly progressive and
nonspecific and include fatigue, weight loss, fever, and
chronic back pain. Neurologic symptoms are found on
presentation in 75% of cases and include reduced sensual
functions, paraparesis, and impaired vegetative regulation
of organ functions.
Because symptoms are unspecific and because spinal TB
is a rare cause of spinal cord compression, diagnosis is often
delayed. Imaging examinations include plain radiographs
to visualize the vertebral alignment and major bony de-
structions. CT scans allow examination of the precise extent
of bone involvement. Granulomatous processes within the
spinal canal can be visualized by myelography or magnetic
resonance imaging.3 CT-guided needle biopsy and micro-
biologic identification of M tuberculosis may confirm the
diagnosis.3
For tuberculous spondylodiscitis, therapeutic options
include antituberculous medication and external bracing.
Fig 2. Computed tomographic scan displaying the aneu
**maximum sagittal diameter, 55 mm).In the case of even mild neurologic symptoms, markedcollapse of the vertebral body, or narrowing of the spinal
canal, surgical intervention is recommended.3,6
After penetration of the anterior longitudinal liga-
ments, microbial pathogens may travel along natural tissue
plains to infect neighboring structures and organs, includ-
ing the thoracoabdominal aorta. As a surgical approach, in
situ repair, including meticulous surgical debridement, is
generally preferred. Primary suture of the pseudoaneurysm
and synthetic patch closure have also been performed suc-
cessfully.4,5 Successful endovascular treatment of tubercu-
lous aortic aneurysms has been reported7; however, we do
favor open surgery, which facilitates debridement of the
infected tissue.
Debate continues concerning the type of graft material
that should be used in infected sites. Experimental studies
have shown the advantage of antibiotic-soaked grafts over
silver-coated and untreated material.8-10 Vascular allografts
have been used for aortic reconstruction in infected areas
with good short- and long-term results; they decrease the
risk of graft infection compared with untreated vascular
prostheses.11-13 However, no data exist comparing long-
eroding T11 (*maximum transverse diameter, 67 mm;rysmterm results of homografts vs antibiotic-bonded vascular
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a maximum of 4 weeks at 4°C in a solution for organ
preservation are excellent. Because of the high numbers of
organ transplantations performed at our institution, vascu-
lar homografts are frequently available for the treatment of
graft infections and mycotic aneurysms (unpublished data).
After surgery, patients receive bacteriogram-guided an-
tibiotic treatment for 6 to 12 weeks. In the case of pulmo-
nary and extrapulmonary TB caused by a fully susceptible
pathogen, a 6-month combination therapy consisting of
isoniazid, rifampin, ethambutol, and pyrazinamide for the
initial 2 months and another 4 months with isoniazid and
rifampin is currently recommended.14 The prolonged ap-
plication of antituberculous medication for 12 months was
indicated by the recurrence that we encountered in this
case.
Tuberculous aortic aneurysms are a rare but potentially
devastating complication of infections with M tuberculosis.
In this case of a patient with a combined tuberculous
spondylodiscitis and tuberculous aortic aneurysm, an aortic
reconstruction using homograft material followed by de-
bridement and stabilization of the spine and adequate
antimicrobial chemotherapy was successfully performed.
REFERENCES
1. Barnes PF, Barrows SA. Tuberculosis in the 1990s. Ann Intern Med
1993;119:400-10.
2. Raviglione MC, Snider DEJ, Kochi A. Global epidemiology of tuber-
culosis: morbidity and mortality of a worldwide epidemic. JAMA 1995;
273:220-6.
3. Rezai AR, Lee M, Cooper PR, Errico TJ, Koslow M. Modern manage-
ment of spinal tuberculosis. Neurosurgery 1995;36:87-98.4. Long R, Guzman R, Greenberg H, Safneck J, Hershfield E. Tubercu-
lous mycotic aneurysm of the aorta. Chest 1999;115:522-31.5. Forbes TL, Harris JR, Nie RG, Lawlor DK. Tuberculous aneurysm of
the supraceliac aorta. Vasc Endovasc Surg 2004;38:93-7.
6. A 10-year assessment of a controlled trial comparing debridement and
anterior spinal fusion in the management of tuberculosis of the spine in
patients on standard chemotherapy in Hong Kong. Eighth Report of
the Medical Research Council Working Party on Tuberculosis of the
Spine. J Bone Joint Surg Br 1982;64:393-8.
7. Liu WC, Kwak BK, Kim KN, Kim SY, Woo JJ, Chung DJ, et al.
Tuberculous aneurysm of the abdominal aorta: endovascular repair
using stent grafts in two cases. Korean J Radiol 2000;1:215-8.
8. Hernandez-Richter T, Schardey HM, Wittmann F, Mayr S, Schmitt-
Sody M, Blasenbreu S, et al. Rifampin and Triclosan but not silver is
effective in preventing bacterial infection of vascular Dacron graft
material. Eur J Vasc Endovasc Surg 2003;26:550-7.
9. Ghiselli R, Giacometti A, Goffi L, Cirioni O,Mocchegiani F, Orlando F,
et al. Prophylaxis against Staphylococcus aureus vascular graft infection
with mupirocin-soaked, collagen-sealed Dacron. J Surg Res 2001;99:
316-20.
10. Vicaretti M, Hawthorne W, Ao PY, Fletcher JP. Does in situ replace-
ment of a staphylococcal infected vascular graft with a rifampicin
impregnated gelatin sealed Dacron graft reduce the incidence of subse-
quent infection? Int Angiol 2000;19:158-65.
11. Vogt PR, Brunner-La Rocca HP, Carrel T, von Segesser LK, Ruef C,
Debatin J, et al. Cryopreserved arterial allografts in the treatment of
major vascular infection: a comparison with conventional surgical tech-
niques. J Thorac Cardiovasc Surg 1998;116:965-7.
12. Vogt PR, von Segesser LK, Goffin Y, Pasic M, Turina MI. Cryopre-
served arterial homografts for in situ reconstruction of mycotic aneu-
rysms and prosthetic graft infection. Eur J Cardiothorac Surg 1995;9:
502-6.
13. Knosalla C, Weng Y, Yankah AC, Hofmeister J, Hetzer R. Using aortic
allograft material to treat mycotic aneurysms of the thoracic aorta. Ann
Thorac Surg 1996;61:1146-52.
14. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC,
Friedman LN, et al. American Thoracic Society/Centers for Disease
Control and Prevention/Infectious Diseases Society of America: treat-
ment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62.Submitted May 6, 2005; accepted Jul 7, 2005.
